August 8, 2023
“A beaten down micro-cap biotech company, Vistagen Therapeutics Inc., notched its best day ever, surging by as many as four digits after its experimental nasal spray for social anxiety disorder hit targets in a late-stage trial. The drug developer’s stock… Continue Reading…
Recent Comments